Suppressors of cytokine signaling (SOCS) are negative feedback inhibitors of cytokine and growth factor signal transduction. Although the effects of SOCS proteins on the Jak-STAT pathway have been well characterized, their role in the regulation of other signaling modules is not well understood. In the present study, we demonstrate that SOCS3 physically interacts with the SH2/SH3-containing adapter proteins Nck and Crk-L, which are known to couple activated receptors to multiple downstream signaling pathways and the actin cytoskeleton. Our data show that the SOCS3/Nck and SOCS3/Crk-L interactions depend on tyrosine phosphorylation of SOCS3 Y221 within the conserved SOCS box motif, and intact SH2 domains of Nck and Crk-L. Furthermore, SOCS3 Y221 forms a Y-x-x-P motif, which is a consensus binding site for the Nck and Crk-L SH2 domains. Expression of SOCS3 in NIH3T3 cells induces constitutive recruitment of a Nck-GFP fusion protein to the plasma membrane and constitutive tyrosine phosphorylation of endogenous Nck.
Summary:
Suppressors of cytokine signaling (SOCS) are negative feedback inhibitors of cytokine and growth factor signal transduction. Although the effects of SOCS proteins on the Jak-STAT pathway have been well characterized, their role in the regulation of other signaling modules is not well understood. In the present study, we demonstrate that SOCS3 physically interacts with the SH2/SH3-containing adapter proteins Nck and Crk-L, which are known to couple activated receptors to multiple downstream signaling pathways and the actin cytoskeleton. Our data show that the SOCS3/Nck and SOCS3/Crk-L interactions depend on tyrosine phosphorylation of SOCS3 Y221 within the conserved SOCS box motif, and intact SH2 domains of Nck and Crk-L. Furthermore, SOCS3 Y221 forms a Y-x-x-P motif, which is a consensus binding site for the Nck and Crk-L SH2 domains. Expression of SOCS3 in NIH3T3 cells induces constitutive recruitment of a Nck-GFP fusion protein to the plasma membrane and constitutive tyrosine phosphorylation of endogenous Nck.
Our findings suggest that SOCS3 regulates multiple cytokine and growth factor-activated signaling pathways by acting as a recruitment factor for adapter proteins.
Running title: SOCS3 binds the Nck and Crk-L adapter proteins ligated by the EcoR I and BamH I sites into pEGFP-N1, which contains the GFP coding sequence inframe. All PCR products were sequenced in their entirety.
PCDNA-Crk-L expression vector was provided by Dr. Ronald Herbst, DNAX Research Inc., Palo Alto, CA. The Crk-L coding sequence was cloned by PCR amplification using a 5' primer encoding a NdeI site at the start codon and a 3' primer encoding a ClaI restriction site in place of the stop codon.
The PCR product was cloned into our pME18S C-terminal FLAG tag mammalian expression vector, fusing the Crk-L cDNA sequence to the FLAG tag at its 3' end (36) . Crk-L R39A was generated using a fusion PCR approach with overlapping (sense and antisense) mutagenic oligonucleotide primers encoding the point mutation. The 5' PCR primer spanned the 5' coding sequence of Crk-L preceded by a NdeI site at the start codon the 3' primer spanned the unique NaeI site in the Crk-L cDNA. The mutant PCR product was swapped with the WT Crk-L NdeI-NaeI fragment from pME18S-Crk-L-FLAG vector.
Transfections/Infections-293T and PlatE cells were transfected with Effectene lipid-based transfection reagent (Qiagen, Crawley, UK) according to the manufacturer's instructions. For retroviral infections, 2 ml of supernatant from transfected PlatE cells was mixed with polybrene (8mg/ml final concentration)(Sigma, St. Louis, MO) and added to NIH3T3 cells in 2 ml of media at 48 h and 72 h after PlatE transfections. After 48 hours of infection, the cells were washed once and resuspended in fresh culture medium. Cells stably expressing the GFP fusion constructs were sorted by flow cytometry for green fluorescent protein expression.
Running title: SOCS3 binds the Nck and Crk-L adapter proteins NIH3T3 fibroblasts with 50ng/ml PDGF BB resulted in robust SOCS3 expression and tyrosine phosphorylation at the 1hr and 2hr time points. Furthermore, p120 RasGAP was found in SOCS3
immunoprecipitates from PDGF-treated cells ( figure 1, panel A) . We examined the sequences surrounding SOCS3 Y204 and Y221 and found that Y221 forms part of a Y-x-x-P motif, which is a consensus binding site for the RasGAP SH2 domains (Table I) . The Y-x-x-P motif has also been shown to interact with the SH2 domains of the Nck and Crk-L adapter proteins (38) (39) (40) (41) (42) (43) . Therefore, we examined the ability of phosphorylated SOCS3 to interact with Nck and Crk-L. Lysates from NIH3T3 cells were precipitated with N-terminal biotinylated peptides spanning both SOCS3 phosphorylation sites (amino acids 200-225). In order to map the Nck and Crk-L binding sites, we measured Nck and Crk-L binding to peptides containing pY204/pY221, single pY204 or pY221 phosphorylation sites, or a control unphosphorylated peptide of identical sequence. As shown in figure 2A , both Nck and Crk-L bound the pY204/pY221 peptide (lanes 2 and 6), as well as the pY221 singly phosphorylated peptide (lanes 4 and 8). However, both molecules failed to interact with the pY204 peptide (lanes 3 and 7) or the unphosphorylated control (lanes 1 and 5).
To further characterize the requirements for SOCS3/Nck and SOCS3/Crk-L interactions, we examined the binding of SOCS3 pY221 phosphopeptide to WT and SH2 domain mutants of Nck and Crk-L. 293T cells were transfected with Myc-tagged Nck or FLAG-tagged Crk-L expression vectors. Included were WT full-length Nck, a Nck SH2 domain mutant (R308A), WT Nck SH2 domain alone (lacking the N-terminal SH3 domains), as well as WT Crk-L and a Crk-L SH2 mutant (R39A). Lysates from transfected cells were precipitated with the SOCS3 phosphopeptide and analyzed by Western blotting with anti-Myc or anti-FLAG antisera to detect Nck or Crk-L. As shown in figure 2B , the binding of Nck and Crk-L to the SOCS3 phosphopeptide was dependent on intact SH2 domains. WT Nck and Crk-L bound strongly to the peptide (lanes 2 and 5), while both SH2 Running title: SOCS3 binds the Nck and Crk-L adapter proteins mutants failed to bind (lanes 3 and 6). In addition, strong binding of the Nck SH2 domain to the SOCS3 peptide demonstrates that an intact SH2 domain is sufficient for the interaction, and the 3 Nterminal SH3 domains of Nck are not required for binding (lane 4).
We next determined whether full-length phosphorylated SOCS3 was capable of interacting with Nck. 293T cells were transiently transfected with a pME18S HA-tagged SOCS3 expression construct either alone or in combination with pME18S-Jak1 vector, to induce SOCS3 tyrosine phosphorylation. Cell lysates were split and precipitated with either GST or GST-Nck proteins coupled to glutathione beads, followed by anti-HA tag Western blotting to detect SOCS3. As shown in figure 2C , full-length SOCS3 interacted with the GST-Nck fusion protein when tyrosine phosphorylated (lane 4), while unphosphorylated SOCS3 failed to interact with Nck (lane 3).
In a previous report, we determined that stimulation of fibroblasts with PDGF for one hour induces SOCS3 expression and tyrosine phosphorylation (35) . Thus, in order to determine 
Discussion:
In this study, we present evidence that SOCS3 expression and tyrosine phosphorylation are induced by activated RTKs, and that endogenous phosphorylated SOCS3 interacts with the Nck and Crk-L adapter proteins in growth factor-stimulated cells. Our data also suggest that SOCS3
regulates the activation and subcellular localization of Nck in response to PDGFRα and PDGFRβ stimulation through a physical interaction between a SOCS box phosphotyrosine residue, pY221 and the SH2 domain of Nck. Our findings suggest that SOCS3 is not only a signal transduction inhibitor but also functions to recruit adapter proteins to activated receptors. Our data expand the potential targets of SOCS proteins and the signaling pathways that they may regulate.
The SH2-containing SOCS subfamily, which includes SOCS1 and SOCS3 was initially characterized as specific inhibitors of the Jak-STAT pathway. Through their SH2 domains and Nterminal kinase inhibitory regions (KIR), both molecules have been shown to bind to a phosphotyrosine residue in the catalytic loop of Jak1 and Jak2, blocking kinase activity and downstream STAT signaling (5-10). In addition, SOCS3 can also form inhibitory complexes with cytokine receptors by directly interacting with phosphorylated tyrosines on the receptor cytoplasmic domains, blocking downstream STAT activation (10-13, 27-33).
More recently, SOCS proteins have been shown to regulate additional signaling pathways by a distinct mechanism involving proteasome-mediated protein destabilization. The SOCS box has been demonstrated to regulate the stability of SOCS proteins as well as SOCS-interacting molecules (4, 14, 15, 37) . SOCS1 accelerates the degradation of Jak1, Jak2, a TEL-Jak2 oncogenic fusion protein, the guanine nucleotide exchange factor (GEF) Vav, and insulin receptor substrates (IRS)-1 and IRS-2 (16-20). Likewise, SOCS3 also destabilizes IRS-1 and IRS-2, modulating insulin signaling and Akt activation, and also induces the degradation of the integrin-associated focal adhesion kinase (FAK) (19, 21) .
In addition, our laboratory has shown that SOCS3 modulates the ERK MAP kinase pathway. We have shown that SOCS3 is phosphorylated on Y204 and Y221 within the conserved SOCS box. In IL-2-stimulated T cells, SOCS3 binds the SH2 domains of the Ras inhibitor p120
RasGAP through pY221 and sustains activation of the ERK MAP kinase pathway (35) . In agreement with this model, it has been shown that macrophages from the SOCS3 knockout very poorly activated ERK in response to IL-6 (44). Thus, there is significant evidence that SOCS proteins have important functions beyond the Jak-STAT pathway.
In the present study, we have extended our original findings and demonstrate that tyrosine phosphorylated SOCS3 binds p120 RasGAP in PDGF-stimulated NIH3T3 fibroblasts as well. The mechanisms regulating the SOCS3/Nck interaction are unknown, but may be related to phosphorylation-dependent SOCS3 protein destabilization. It has been shown by our laboratory and others that the SOCS box, which is a protein-protein interaction domain, regulates the stability of SOCS proteins by physically coupling to elongin C, a component of an E3 ubiquitin ligase containing a cullin (Cul-2 or Cul-5), elongin B, a ring finger protein (Rbx-1), and an E2 ligase (4, 14, 15, 37) . Our previous data have shown that the SOCS3/elongin C interaction stabilizes SOCS3. Phosphorylation of the SOCS box tyrosines Y204 and Y221 disrupts the SOCS3/elongin C complex and accelerates SOCS3 degradation (37) . Thus, a possible explanation for the transient nature of the SOCS3/Nck complexes in fibroblasts is that SOCS3 is destabilized by tyrosine phosphorylation and the complex is targeted for proteasome-mediated degradation. However, we cannot exclude the possibility that the complex is disrupted by a different mechanism, such as binding of competing signaling proteins to Nck or SOCS3, or decreased SOCS3 tyrosine phosphorylation at late time points.
Our current data as well as a previous study from our laboratory (35) have demonstrated that RasGAP, Nck and Crk-L can all bind to a single phosphotyrosine residue on SOCS3. Our findings raise the possibility that these proteins compete for phosphorylated SOCS3 during a cytokine or growth factor response, with consequences for downstream signaling. We may postulate that engagement of one of these proteins would block or reduce the effects of SOCS3 on the other two binding proteins. The extent and downstream effects of competition for SOCS3 would likely depend on the abundance of phosphorylated SOCS3 within the cell as well as the relative expression levels, accessibility, and affinities of RasGAP, Nck, and Crk-L for SOCS3. Thus, we might expect that the extent of competition would depend on cellular context and may also be ligand-specific (i.e. different ligands may preferentially induce the formation of specific complexes). On the other hand, in a previous study (37) we analyzed the distribution of SOCS3 in fractionated lysates from cytokinestimulated cells. We found that SOCS3 is present in fractions representing a wide range of molecular weights, which is consistent with the presence of multiple SOCS3-containing signaling complexes.
Thus, although adapter proteins may compete for SOCS3 binding, it is also possible that pools of pYSOCS3 bound to RasGAP, Nck and Crk-L may co-exist within the cell, resulting in coordinate regulation of RasGAP, Nck and Crk-L signaling. We are currently investigating whether SOCS3 forms distinct complexes at different time points during a cytokine or growth factor response, or in response to specific ligands.
One issue that must be addressed is the potential biological function of SOCS3/Nck and SOCS3/Crk-L complexes. We have observed that SOCS3 shares signaling properties with two other adapter proteins, p62 DOK-1 and p56 DOK-2. As shown in Table I Nck and SOCS3 levels were determined by Western blotting with anti-Nck or anti-FLAG antibodies, respectively (panels B and C). Table I 
